339 related articles for article (PubMed ID: 18023151)
1. Efficacy and safety of a single-dose veterinary preparation of ivermectin versus 7-day high-dose albendazole for chronic strongyloidiasis.
Suputtamongkol Y; Kungpanichkul N; Silpasakorn S; Beeching NJ
Int J Antimicrob Agents; 2008 Jan; 31(1):46-9. PubMed ID: 18023151
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of strongyloides in Northern Thailand and treatment with ivermectin vs albendazole.
Nontasut P; Muennoo C; Sa-nguankiat S; Fongsri S; Vichit A
Southeast Asian J Trop Med Public Health; 2005 Mar; 36(2):442-4. PubMed ID: 15916052
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of single and double doses of ivermectin versus 7-day high dose albendazole for chronic strongyloidiasis.
Suputtamongkol Y; Premasathian N; Bhumimuang K; Waywa D; Nilganuwong S; Karuphong E; Anekthananon T; Wanachiwanawin D; Silpasakorn S
PLoS Negl Trop Dis; 2011 May; 5(5):e1044. PubMed ID: 21572981
[TBL] [Abstract][Full Text] [Related]
4. Disseminated strongyloidiasis successfully treated with extended duration ivermectin combined with albendazole: a case report of intractable strongyloidiasis.
Pornsuriyasak P; Niticharoenpong K; Sakapibunnan A
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):531-4. PubMed ID: 15689061
[TBL] [Abstract][Full Text] [Related]
5. Comparative studies on the efficacy of three anthelminthics on treatment of human strongyloidiasis in Okinawa, Japan.
Toma H; Sato Y; Shiroma Y; Kobayashi J; Shimabukuro I; Takara M
Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):147-51. PubMed ID: 11023084
[TBL] [Abstract][Full Text] [Related]
6. Utility of serological follow-up of chronic strongyloidiasis after anthelminthic chemotherapy.
Page WA; Dempsey K; McCarthy JS
Trans R Soc Trop Med Hyg; 2006 Nov; 100(11):1056-62. PubMed ID: 16551471
[TBL] [Abstract][Full Text] [Related]
7. Randomized comparative trial of two high-dose albendazole regimens for uncomplicated human strongyloidiasis.
Singthong S; Intapan PM; Wongsaroji T; Maleewong W
Southeast Asian J Trop Med Public Health; 2006; 37 Suppl 3():32-4. PubMed ID: 17547048
[TBL] [Abstract][Full Text] [Related]
8. Treatment of cutaneous gnathostomiasis with ivermectin.
Kraivichian K; Nuchprayoon S; Sitichalernchai P; Chaicumpa W; Yentakam S
Am J Trop Med Hyg; 2004 Nov; 71(5):623-8. PubMed ID: 15569795
[TBL] [Abstract][Full Text] [Related]
9. Hyperinfection strongyloidiasis in a liver transplant recipient treated with parenteral ivermectin.
Lichtenberger P; Rosa-Cunha I; Morris M; Nishida S; Akpinar E; Gaitan J; Tzakis A; Doblecki-Lewis S
Transpl Infect Dis; 2009 Apr; 11(2):137-42. PubMed ID: 19144097
[TBL] [Abstract][Full Text] [Related]
10. Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis.
Turner SA; Maclean JD; Fleckenstein L; Greenaway C
Am J Trop Med Hyg; 2005 Nov; 73(5):911-4. PubMed ID: 16282302
[TBL] [Abstract][Full Text] [Related]
11. A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children.
Marti H; Haji HJ; Savioli L; Chwaya HM; Mgeni AF; Ameir JS; Hatz C
Am J Trop Med Hyg; 1996 Nov; 55(5):477-81. PubMed ID: 8940976
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: results of an open study of 60 cases.
Datry A; Hilmarsdottir I; Mayorga-Sagastume R; Lyagoubi M; Gaxotte P; Biligui S; Chodakewitz J; Neu D; Danis M; Gentilini M
Trans R Soc Trop Med Hyg; 1994; 88(3):344-5. PubMed ID: 7974685
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, multicenter clinical trial on the efficacy of ivermectin against intestinal nematode infections in China.
Wen LY; Yan XL; Sun FH; Fang YY; Yang MJ; Lou LJ
Acta Trop; 2008 Jun; 106(3):190-4. PubMed ID: 18452885
[TBL] [Abstract][Full Text] [Related]
14. Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin.
Marty FM; Lowry CM; Rodriguez M; Milner DA; Pieciak WS; Sinha A; Fleckenstein L; Baden LR
Clin Infect Dis; 2005 Jul; 41(1):e5-8. PubMed ID: 15937753
[TBL] [Abstract][Full Text] [Related]
15. Double-dose ivermectin vs albendazole for the treatment of gnathostomiasis.
Nontasut P; Claesson BA; Dekumyoy P; Pakdee W; Chullawichit S
Southeast Asian J Trop Med Public Health; 2005 May; 36(3):650-2. PubMed ID: 16124432
[TBL] [Abstract][Full Text] [Related]
16. Albendazole is effective treatment for chronic strongyloidiasis.
Archibald LK; Beeching NJ; Gill GV; Bailey JW; Bell DR
Q J Med; 1993 Mar; 86(3):191-5. PubMed ID: 8483992
[TBL] [Abstract][Full Text] [Related]
17. Tolerability of ivermectin in gnathostomiasis.
Bussaratid V; Krudsood S; Silachamroon U; Looareesuwan S
Southeast Asian J Trop Med Public Health; 2005 May; 36(3):644-9. PubMed ID: 16124431
[TBL] [Abstract][Full Text] [Related]
18. Comparison of ivermectin and albendazole treatment for gnathostomiasis.
Nontasut P; Bussaratid V; Chullawichit S; Charoensook N; Visetsuk K
Southeast Asian J Trop Med Public Health; 2000 Jun; 31(2):374-7. PubMed ID: 11127342
[TBL] [Abstract][Full Text] [Related]
19. Mazzotti reaction after presumptive treatment for schistosomiasis and strongyloidiasis in a Liberian refugee.
Olson BG; Domachowske JB
Pediatr Infect Dis J; 2006 May; 25(5):466-8. PubMed ID: 16645520
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for strongyloidiasis hyperinfection and clinical outcomes.
Asdamongkol N; Pornsuriyasak P; Sungkanuparph S
Southeast Asian J Trop Med Public Health; 2006 Sep; 37(5):875-84. PubMed ID: 17333728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
